Most people know us as a manufacturer of consumer products such as photographic films. But Agfa is much more, we supply all kinds of high-end 'imaging' solutions.  Hardware, software and digital imaging products account for an increasing part of our turnover. This is true for our consumer products, but also in the other divisions such as Prepress Systems, HealthCare and Industrial Imaging. 

Le groupe est divisé en trois segments d'activité : L'imagerie grand public, la high tech au service du quotidien : des films, des pellicules de très haute qualité, mais aussi des scanners, des logiciels de gestion d'images, des appareils photos numériques.

Agfa-Gevaert announces preliminary Q3 figures 
Mortsel (Belgium), October 17, 2007
Agfa-Gevaert today announced preliminary figures for the third quarter. During this period, several internal and external factors had a considerable negative impact on the Group's results. Although the Group succeeded in substantially lowering its sales and general administration costs, profitability was affected by continuous high raw material costs (plus 17 million Euro compared to Q3 2006) and the further depreciation of the US dollar which weakened the Group's competitiveness, especially in HealthCare. In addition, there was a delay in the roll-out of Graphics' industrial inkjet systems.
In the third quarter, Agfa Graphics' sales remained stable compared to last year, contrary to the decline during the first half of 2007 which resulted from the 2006 price increases and the discontinuation of some unprofitable analog business. Sales amounted to 400 million Euro, a slight increase in local currency. Despite the negative impact of high aluminum and silver costs, the profitability of the prepress segment (EBIT margin of approx. 7 percent) has slightly improved due to the implementation of the cost savings plan. 
On the other hand, the market introduction of Agfa Graphics' industrial inkjet portfolio is taking more time than foreseen. Due to this delay, and taking into account the drupa fair in June 2008, Agfa expects the inkjet segment to be profitable in 2009.
Taking into account all these elements, the recurring EBIT of Graphics for the third quarter will be in the range of 12 to 15 million Euro. Sales and profitability of the fourth quarter are expected to be in line with the fourth quarter of last year.
Sales of Agfa HealthCare amounted to 319 million Euro in the third quarter, a decline of 6 percent compared to last year or 3 percent at stable exchange rates. The main reasons for the decline were the strength of the Euro with an additional effect on price erosion and the decline in medical film sales in some regions due to unexpected high stock levels at dealers. Recurring EBIT was affected by the weaker sales, negative mix and currency effects and higher silver costs. In addition, one-off effects for a total of 7 million Euro, were booked during the quarter. As a result, recurring EBIT for the third quarter will be in the range of 5 to 8 million Euro.
After the unsatisfactory results of the second quarter, several measures were taken to improve HealthCare's operational performance. 
The HealthCare management has been changed and reinforced. The former HealthCare President left the company and the search for his replacement is ongoing. Carl Verstraelen has already joined the business group as Vice President Finance and Controlling in September.
The business group is in the process of being reorganized in order to increase the accountability and responsibility of the business units. 
The portfolio of trade receivables was fully analyzed. During the fourth quarter, the focus will be on reducing overdues, e.g. by centralizing the collection of receivables. 
The first beneficial effects of the stricter discipline related to the costs savings program were realized. As a result, SG&A costs decreased by 9 percent in the third quarter, compared to a decrease by 4 percent in the first 6 months. Additional effects from these savings will be seen in the next few quarters. 
Regarding the international roll-out of ORBIS and in order to speed up the profitability, it was decided to harvest in 2008 on the investments already made. This will allow the Group to better align the necessary investments related to the roll-out with the expected revenue stream

Agfa-Gevaert reports second quarter results
Group sales increased 0.8 percent (excluding currency effects) 
Net result increased 50 percent to 42 million Euro 
New timeline for demerger 
Mortsel (Belgium), July 31, 2007 - Agfa-Gevaert today announced its second quarter results. Group sales increased 0.8 percent (excluding currency effects) to 845 million Euro. Both HealthCare and Specialty Products reported solid sales, while Graphics' sales decreased due to the ongoing decline of analog prepress and the discontinuation of some unprofitable business. The Group succeeded in lowering its sales and general administration costs by 6.2 percent. Due to the significant impact of high raw materials costs, recurring EBIT decreased to 55 million Euro (or 6.5 percent of sales), in comparison with the very strong second quarter in 2006. The Group's net result increased from 28 million Euro to 42 million Euro.

Agfa-Gevaert reports first quarter results
7.4 percent growth in recurring EBIT on modest sales growth excluding currency effects 
SG&A costs decreased by 7.3 percent 
Net profit more than doubled to 41 million Euro
Mortsel (Belgium), May 3, 2007 - Agfa-Gevaert today announced its first quarter results. Group sales reached 786 million Euro, an increase of 0.4 percent (excluding currency effects) compared to the first quarter of 2006. The Group's recurring EBIT grew 7.4 percent to 58 million Euro (or 7.4 percent of sales), as positive mix effects and the reduction of expenses more than offset higher silver and aluminum costs. The Group's net result more than doubled from 20 million Euro to 41 million Euro.
The shift from analog to digital and IT accelerated both in Graphics and in HealthCare. In Graphics, this resulted in solid margins for the prepress segment. In HealthCare, strong sales were generated for Computed Radiography and IT solutions, resulting in growing market shares. Specialty Products again reported very strong margins. 

04/04/07 Agfa HealthCare signs new PACS agreement with Novation to provide diverse radiology and cardiology PACS and RIS solutions
Agfa HealthCare receives contract awards in three product categories
Mortsel, Belgium - April 4, 2007 - 18:00 CET
Agfa HealthCare announces today that Novation, the industry's leading health care contracting services company, has awarded the company contracts,  through its competitive bid process, to provide radiology Picture Archiving and Communications System (PACS) solutions, Radiology Information System (RIS) solutions and cardiology PACS to the University Health System Consortium, VHA Inc., and HealthCare Purchasing Partners International (HPPI) member facilities. 
The contracts were awarded in all three product categories included in the bid process and Agfa HealthCare can provide value-added services associated with the three contract awards, including Professional Services IMPAX(TM) Clinical Module and Enterprise Clinical Portal, as well as Agfa HealthCare's Fast-Forward to Digital(TM), Fee-Per-Exam, Turnkey Programs, and more. 

28/03/07 Agfa HealthCare wins major German University Hospital IT contract after pan-European pitch
University Clinic of Schleswig-Holstein awards Agfa HealthCare cross-campus implementation of its ORBIS Hospital Information System with Radiology Information System and IMPAX PACS
Bonn, Kiel / Mortsel, Belgium - March 28, 2007 - 16:00 CET
Agfa HealthCare announces today that the Managing Board of the University Clinic of Schleswig-Holstein, one of the three largest university hospitals in Germany, awarded Agfa HealthCare the contract for the cross-campus introduction of its ORBIS(TM) Hospital Information System (HIS), with an integrated Radiology Information System (RIS) and IMPAX(TM) Picture Archiving and Communication System (PACS). The contract has already gone into effect.  ORBIS has already been deployed in over 750 institutions across continental Europe with more than 450,000 daily users. 
The changeover to ORBIS and IMPAX will allow the University Clinic of Schleswig-Holstein to improve its processes in Patient Care (physicians, nursing staff), Patient Administration (admissions, billing), and Research and Teaching. Agfa HealthCare will introduce a unified patient administration and billing solution in the early stages, as well as the first stage of the Hospital Workplace System and the Radiology Information System with PACS. 
The decision in favor of Agfa HealthCare was preceded by a preparatory period lasting more than two and a half years. The invitation to bid for this major IT project, whose sponsors include the German Research Federation (Deutsche Forschungsgemeinschaft, DFG), was issued throughout Europe in September 2006. 

28/02/07  Agfa-Gevaert to split into three independent, publicly traded companies - Fourth quarter and full year impacted by restructuring charges for savings plan
Agfa-Gevaert to split into three independent, publicly traded companies
Demerger of Agfa-Gevaert NV into three separately listed companies 
Three independent companies best positioned to pursue own strategies 
Split to be completed by year-end
Fourth quarter and full year impacted by restructuring charges for savings plan
Strong fourth quarter sales in HealthCare and Specialty Products 
Improved profitability in Graphics 
Continued significant impact of raw material costs 
Net loss in fourth quarter due to costs related to savings plan 
Full year net profit of 15 million Euro 
Annual dividend of 50 Eurocents to be proposed
Demerger
Agfa-Gevaert announced that its Board of Directors has completed the strategic review of the company and decided that it is in the best interest of the Group, the customers, the shareholders and the employees to split into three independent, listed companies - representing the activities of Agfa Graphics, Agfa HealthCare and Agfa Materials - by the end of 2007. The Board has concluded that the businesses have the size, fundamental strength, industry leadership, and organizational talent to succeed independently in their respective markets. The separate companies will be better positioned to pursue their own distinct strategic objectives and will have direct access to the capital markets. Upon completion of the demerger, shareholders of Agfa-Gevaert will, instead of holding one Agfa-Gevaert share, hold shares in three separately listed companies. 
Fourth quarter results
Agfa-Gevaert today also announced its fourth quarter results. Excluding currency effects, Group sales increased 3.9 percent (1.5 percent including currency effects) compared to the fourth quarter of 2005. The Group's fourth quarter recurring EBIT decreased due to the significant increase of silver and aluminium costs. Agfa also booked a restructuring charge of 122 million Euro in the fourth quarter, as the negotiations about the social plans for, amongst others, the Belgian operations were concluded. As a result, a net loss of 25 million Euro was recorded in the last quarter. 

Agfa-Gevaert on AgfaPhoto
Mortsel (Belgium), January 16, 2007
The German and international press have recently published various articles on an alleged payment due of 55 million Euro by Agfa-Gevaert to the insolvent AgfaPhoto GmbH in Germany.
Immediately after the insolvency filing of AgfaPhoto in May 2005, Agfa-Gevaert has, in order to support the preliminary receiver and the new management in the objective to preserve the operations and employment of AgfaPhoto, agreed to continue to perform certain distribution, invoicing and collection activities for the account of AgfaPhoto and its subsidiaries. To this end an agreement was signed with AgfaPhoto GmbH's preliminary receiver, Dr. Ringstmeier, and the new management of AgfaPhoto GmbH according to which Agfa-Gevaert is to pay for the goods supplied by AgfaPhoto GmbH only when the end customer has paid its invoices and to the extent that Agfa-Gevaert itself is not exposed to additional commercial and financial risks.
Today a substantial amount of receivables against end customers is still outstanding, meaning that these still need to be collected. Other, less significant amounts have been collected but it is unclear whether these are wholly or partially due to AgfaPhoto GmbH's receiver or to other parties.
Agfa-Gevaert remains willing to co-operate with all parties concerned in order to resolve the pending issues under the distribution arrangements; Agfa-Gevaert is also prepared to simply put the collected amounts in an escrow account until a court decides on the allocation of these amounts.
The company regrets having to express itself on this issue through the media and expects that the matter be discussed in a constructive way where it belongs, that is among the parties concerned.